
Endocrinologist

No OPD information available
Gestational Diabetes
Intrahepatic Cholestasis of Pregnancy
Low Blood Pressure
Type 2 Diabetes (T2D)
David H. Mcintyre is a male healthcare provider who helps patients with different health conditions like Gestational Diabetes, Intrahepatic Cholestasis of Pregnancy, Low Blood Pressure, and Type 2 Diabetes (T2D). He is skilled in treating these conditions and uses special techniques to help his patients feel better.
David H. Mcintyre talks to his patients in a friendly and caring way, making them feel comfortable and heard. Patients trust him because he listens to their concerns and explains things clearly. He uses simple language that everyone can understand, which helps patients feel more at ease.
To stay updated with the latest medical knowledge, David H. Mcintyre reads research papers and attends conferences. This helps him learn new things and improve his treatments for patients. He shares his knowledge with colleagues and works together with other medical professionals to provide the best care for patients.
David H. Mcintyre's work has had a positive impact on many patients' lives. By treating conditions like Gestational Diabetes and Type 2 Diabetes, he has helped patients improve their health and feel better. His research on dietary fiber and gut microbiota has also contributed to the medical field's understanding of these important topics.
One of David H. Mcintyre's notable publications is about how dietary fiber affects gut bacteria during pregnancy. He has also conducted a clinical trial called "Stepping Up to Health - Walking Exercise and Nutrition to Reduce Diabetes Risk for You (WENDY)," which aimed to help people reduce their risk of diabetes through exercise and nutrition.
In summary, David H. Mcintyre is a caring and knowledgeable healthcare provider who works hard to improve his patients' health. Through his treatments, research, and collaborations with other medical professionals, he has made a positive impact on many lives.
Enrollment Status: Completed
Published: May 23, 2017
Intervention Type: Behavioral
Study Drug:
Study Phase: Not Applicable
